Stockreport

Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA

ARADIGM CORP COMMON STOCK  (ARDM) 
US:NASDAQ Investor Relations: investor.aradigm.com
PDF HAYWARD, Calif.--(BUSINESS WIRE)-- Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) submitted responses to the European Medicines Agency (EMA [Read more]